6 results about "Achyranthes aspera" patented technology

This invention relates to a traditional Chinese medicine composition, its preparation method, and its application. The traditional Chinese medicine composition of this invention comprises two components: Achyranthes bidentata and Glycyrrhiza uralensis. By taking the traditional Chinese medicine composition of this invention, the overall effective rate in treating frozen shoulder reaches 90%, and the cure rate exceeds 60%.

A herbal composition for the treatment of a variety of metabolic disorders in mammals, especially human beings, is disclosed. A method of preparing the herbal composition is also disclosed. The herbal composition treats and alleviates a plurality of metabolic disorders, including central obesity, high blood pressure levels, high blood sugar levels, stress-induced fatigue, and type 2 diabetes. The herbal composition comprises the extracts of Dolichos lablab, Achyranthes aspera, and at least one of Cinnamomum zeylanicum and Cinnamomum cassia. The aforementioned extracts are present in the herbal composition at a predetermined weight range. The aforementioned extracts are standardized to contain active compounds, including proanthocyanidins, saponins, polyphenols, and tannins, in a predetermined concentration and in predetermined purity levels. The herbal composition causes an enhancement of adiponectin levels and high-density lipoprotein (HDL) levels, and a reduction in the accumulation of adipose tissue, total cholesterol levels, triglyceride levels, and low-density lipoprotein (LDL) levels.

This invention relates to the field of pharmaceutical technology, specifically to a pharmaceutical composition for treating functional uterine bleeding, its preparation method, and its application. The pharmaceutical composition consists of *Rheum palmatum*, *Panax ginseng*, *Smilax china*, *Achyranthes bidentata*, and *Gentiana scabra*. The preparation method involves weighing the five herbs according to the prescribed amounts, extracting with ethanol, filtering, and recovering the ethanol. The residue after ethanol extraction is then soaked in water and with cellulase under specific conditions, boiled, and filtered to obtain an enzymatic extract. The ethanol extract and the enzymatic extract are combined and concentrated to a thick paste. Appropriate excipients are added to the thick paste to formulate the corresponding dosage form. This drug has the functions of promoting blood circulation, regulating qi, stopping bleeding, and regulating menstruation, and is used to treat functional uterine bleeding. Furthermore, the pharmaceutical composition is formulated into appropriate dosage forms using modern pharmaceutical preparation technology, making its clinical efficacy in treating functional uterine bleeding more significant and its onset of action faster.

The invention relates to a method for constructing HPLC characteristic chromatograms of a Yumai decoction reference sample, two sets of HPLC methods are adopted to comprehensively characterize component characteristics of four medicines in a Yumai decoction prescription, the first set of HPLC characteristic chromatogram determines 10 characteristic peaks, and the first set of HPLC characteristic chromatogram belongs to six characteristic peaks of the medicine flavor of prepared rehmannia root, and the second set of HPLC characteristic chromatogram belongs to six characteristic peaks of the medicine flavor of Yumai decoction. The components are respectively catalpol, adenosine, 5-hydroxymethylfurfural, rehmannia D, verbascoside and isoacteoside; the rhizoma anemarrhenae has three characteristic peaks, namely neomangiferin, mangiferin and isomangiferin; the first set of HPLC characteristic chromatogram determines five characteristic peaks which belong to beta-ecdysterone, the second set of HPLC characteristic chromatogram determines five characteristic peaks which belong to five characteristic peaks of radix ophiopogonis, and two peaks of the characteristic peaks are identified to be methylophiopogonanone A and methylophiopogonanone B respectively; the two sets of specific chromatogram methods established by the invention have good performance and better pertinence, can comprehensively characterize the component characteristics of the four medicines in the Yumai decoction prescription, and can effectively monitor the quality of the Yumai decoction preparation.

The invention belongs to the technical field of traditional Chinese medicines, and relates to an external traditional Chinese medicine composition for treating limb numbness after cerebral infarction as well as a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 15 parts of lycopodium clavatum, 15 parts of radix achyranthis bidentatae, 15 parts of parasitic loranthus, 15 parts of ligusticum wallichii, 15 parts of caulis spatholobi, 15 parts of acanthopanax, 10 parts of garden balsam stem, 10 parts of earthworm, 10 parts of cassia twig, 10 parts of fried mulberry twig, 10 parts of radix angelicae pubescentis, 10 parts of angelica sinensis, 10 parts of radix paeoniae rubra, 15 parts of eucommia ulmoides, 6 parts of achyranthes aspera and 10 parts of astragalus membranaceus. The traditional Chinese medicine composition effectively improves limb numbness of a patient, increases the degree of activity of joint muscles and relieves the feeling of muscle numbness, so that the movement function and the daily life activity ability of the patient are improved, and the life quality of the patient is improved.

A system for the extraction of bioactive phytochemicals from Achyranthes aspera seeds, comprising an extraction chamber, a solvent supply unit for providing hydroalcoholic mixtures and a filtration module for producing a clarified extract suitable for applications in the field of obesity treatment.